Key Findings:  The authors summarize that anti-inflammatory agents, vitamin D3-receptor analogs, and cannabinoids represent treatment modalities currently under investigation for use in LUTS patients.
Type of Study:  Meta-analysis
Study Result:  Positive
Study Location(s):  Greece
Year of Pub:  2016
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Unspecified